Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/11/2011 → 31/10/2015 |
Funding
- EC European Commission: £686,979.00
Pharmacogenomic biomakers as a clinical decision making tools for clozapine treatment of schizophrenia. CRESTAR (RTD)
- Maccabe, James (Primary Investigator)
- Breen, Gerome (Co-Investigator)
- Brittain, Philip (Co-Investigator)
Project: Research